MCM-12156-61385
3 vaccinations
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 221 / VA
- Registered
- 2022-06-30
- Relationship
- Child or adolescent in my care
- Guardian
- 49L-20961-05189
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-08
Dose 1 — Pfizer-BioNTech
-
2021-11-29
Dose 2 — Pfizer-BioNTech
-
2022-06-01
Dose 3 — Pfizer-BioNTech
-
2022-06-30
Registered in v-safe
- 2022-06-30
- 2022-07-12
- 2022-07-13
-
2022-12-02
Survey response — 6 months, dose 3, dependentMedDRA: Viral infection — Feeling: GoodFree text: viral illnessesMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-08 | Pfizer-BioNTech | No |
| 2 | 2021-11-29 | Pfizer-BioNTech | No |
| 3 | 2022-06-01 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 3, dependent
Symptoms: viral illnesses
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release